HomeVenture Capital

Venture Capital

Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease

Life Sciences Times - October 16, 2026

Venture Capital

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

Life Sciences Times - October 15, 2026

Venture Capital

Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies

Life Sciences Times - October 13, 2026

Venture Capital

Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy

Life Sciences Times - October 5, 2026

Venture Capital

ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies

Life Sciences Times - September 29, 2026

Venture Capital

Carta Healthcare Secures $20 Million Series B Funding

Life Sciences Times - November 2, 2022 0

Venture Capital

Applied Industrial Technologies Acquires Automation, Inc.

Life Sciences Times - November 2, 2022 0

Venture Capital

Concerto Biosciences Raises $23 Million in Series A to Advance Product Development, Expand Pipeline

Life Sciences Times - November 2, 2022 0

Venture Capital

Applied UV Announces New Debt Financings of $7.5 Million in Aggregate to Support Growth

Life Sciences Times - November 1, 2022 0

Venture Capital

Acclaimed Life Sciences Leaders Launch Impact Investment Firm to Accelerate Health Equity

Life Sciences Times - November 1, 2022 0

Venture Capital

Johnson & Johnson to Acquire Abiomed

Life Sciences Times - November 1, 2022 0

Venture Capital

Bright Machines Raises $132M in New Funding to Expand Intelligent Automation in Manufacturing

Life Sciences Times - October 31, 2022 0

Venture Capital

Thermo Fisher Scientific to Acquire The Binding Site Group

Life Sciences Times - October 31, 2022 0

Venture Capital

Emerson to Sell Majority Stake in Climate Technologies to Blackstone in Transaction Valuing the Business at $14.0 Billion

Life Sciences Times - October 31, 2022 0

Venture Capital

LatticeFlow Secures $12 Million to Eliminate AI Data and Model Blind Spots in Computer Vision

Life Sciences Times - October 28, 2022 0

Venture Capital

Aspen Surgical Acquires Symmetry Surgical

Life Sciences Times - October 27, 2022 0

Venture Capital

QHP Capital Acquires AutoCruitment

Life Sciences Times - October 27, 2022 0

1...616263...115 Page 62 of 115

Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment

October 23, 2026

Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment

October 23, 2026

Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment

October 23, 2026

Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment

October 23, 2026

Venture Capital

Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies

Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy

ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies

Most Read

Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment

Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment

Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment

Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment

EDITOR PICKS

eGenesis Names Daniel Leblanc Chief Manufacturing and Supply Officer

Takeda Reports Positive Phase 4 Results for ENTYVIO in Ulcerative Colitis Treatment

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

THIS WEEK'S STORIES

Convatec Wins Two Vizient Supplier Excellence Awards for Medical Products and Healthcare Innovation

Thermo Fisher Scientific Reports 9% Revenue Growth to $12.14 Billion in Third Quarter

AstraZeneca, Amgen Report Positive Phase III Results for TEZSPIRE in Eosinophilic Esophagitis

POPULAR CATEGORY

ABOUT US

FOLLOW US